申请人:Laboratorio Chimico Farmaceutico CAUSYTH S.p.A.
公开号:US04259332A1
公开(公告)日:1981-03-31
Novel taurine derivatives of general formula (I) ##STR1## (wherein R.sup.1 is nicotinoyl, 3,4,5-trimethoxybenzoyl or acetylsalicyloyl and R.sup.2 is as defined for R.sup.1 or is --CH.sub.2 CH.sub.2 OR.sup.1) have antilipemic and choleretic activities. The compound in which R.sup.2 .dbd.--CH.sub.2 CH.sub.2 OR.sup.1 and R.sup.1 is acetylsalicyloyl exhibits high antiinflammatory, analgesic and antipyretic activity and is essentially free of the unfavorable effect of acetylsalicylic acid on the stomach.
新型牛磺酸衍生物的一般式(I) ##STR1## (其中R.sup.1为烟酰基、3,4,5-三甲氧基苯甲酰基或乙酰水杨酰基,R.sup.2与R.sup.1定义相同或为--CH.sub.2 CH.sub.2 OR.sup.1) 具有降脂和利胆活性。其中R.sup.2 .dbd.--CH.sub.2 CH.sub.2 OR.sup.1且R.sup.1为乙酰水杨酰基的化合物具有高度的抗炎、镇痛和退热活性,并且基本上没有乙酰水杨酸对胃的不利影响。